38 reports

  • NJOY IN GLOBAL SMOKING CESSATION PRODUCTS MARKET
  • GLOBAL SMOKING CESSATION PRODUCTS MARKET BY TYPE
  • Smoking Cessation
  • GlaxoSmithKline plc
  • ITC Limited
  • Pfizer Inc.
  • Reynolds American Inc.

Nicotine gum is a smoking cessation product, which helps smokers to gradually get off nicotine.

  • Smoking Cessation
  • United States
  • Market Size
  • GlaxoSmithKline plc
  • Novartis AG
  • Smoking Cessation Aids Sales Volume by
  • Global Smoking Cessation Market
  • Smoking Cessation
  • China
  • Trade
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Smoking Cessation Aids Sales Volume by
  • SMOKING CESSATION AIDS INDUSTRY ASSESSMENTS
  • Smoking Cessation
  • China
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.

Smoking Cessation Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Smoking Cessation Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Smoking Cessation pipeline products,

  • Smoking Cessation
  • France
  • Germany
  • Italy
  • Market Size

MEA Smoking Cessation and Nicotine De-addiction Products Market Analysis 2012–2016 and Forecast 2017–2025 ##. ##.

  • Smoking Cessation
  • Asia
  • Europe
  • North America
  • Market Size

Smoking Cessation Products - Market Trends & Insights ##.

  • OTC
  • Smoking Cessation
  • World
  • Demand
  • Market Size

Reimbursement for smoking cessation therapy ##. ##. ##.

  • OTC
  • Smoking Cessation
  • World
  • Market Size
  • SMOKING CESSATION AIDS INDUSTRY ASSESSMENTS
  • Profiles of Smoking Cessation Aids Producers
  • Smoking Cessation
  • China
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.
  • NRT SMOKING CESSATION AIDS IN COLOMBIA - CATEGORY ANALYSIS
  • September 2016
  • OTC
  • Smoking Cessation
  • Colombia
  • Demand

Smoking Cessation Market Forecast ($), UK, 2015 – 2020 The latest research from Fore Pharma, Europe Smoking Cessation Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Smoking Cessation pipeline products, Smoking Cessation ep

  • Smoking Cessation
  • Europe
  • France
  • Germany
  • Market Size

Japan Smoking Cessation Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Smoking Cessation Treatments ##) Smoking Cessation Pipeline ##) Japan Smoking Cessation Epidemiology ##) Marketed Drugs for

  • OTC
  • Smoking Cessation
  • Japan
  • Market Size

France Smoking Cessation Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Smoking Cessation Treatments ##) Smoking Cessation Pipeline ##) France Smoking Cessation Epidemiology ##) Marketed Drugs for

  • OTC
  • Smoking Cessation
  • France
  • Market Size

UK Smoking Cessation Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Smoking Cessation Treatments ##) Smoking Cessation Pipeline ##) UK Smoking Cessation Epidemiology ##) Marketed Drugs for

  • OTC
  • Smoking Cessation
  • United Kingdom
  • Market Size

Italy Smoking Cessation Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Smoking Cessation Treatments ##) Smoking Cessation Pipeline ##) Italy Smoking Cessation Epidemiology ##) Marketed Drugs for

  • OTC
  • Smoking Cessation
  • Italy
  • Market Size

Germany Smoking Cessation Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Smoking Cessation Treatments ##) Smoking Cessation Pipeline ##) Germany Smoking Cessation Epidemiology ##) Marketed Drugs f

  • OTC
  • Smoking Cessation
  • Germany
  • Market Size

Spain Smoking Cessation Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Smoking Cessation Treatments ##) Smoking Cessation Pipeline ##) Spain Smoking Cessation Epidemiology ##) Marketed Drugs for

  • OTC
  • Smoking Cessation
  • Spain
  • Market Size

US Smoking Cessation Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Smoking Cessation Treatments ##) Smoking Cessation Pipeline ##) US Smoking Cessation Epidemiology ##) Marketed Drugs for

  • OTC
  • Smoking Cessation
  • Market Size

MARKET OVERVIEW.............. ## Table ##: Global Smoking Cessation (Nicotine Replacement Therapy & Prescription Drugs) Market (2014) in US$ Million ## Table ##: Nicotine Replacement Therapy (NRT) Smoking Cessation Market by Product Worldwide (2014) - Percentage Share Breakdown by

  • OTC
  • Smoking Cessation
  • World
  • Demand
  • Market Size
  • Smoking cessation products market in the US 2016-2021 ($ billions)
  • Segmentation of market by products
  • Smoking Cessation
  • United States
  • Demand
  • Forecast
  • Market Size
  • Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study
  • Five Key Clinical Profiles
  • Smoking Cessation
  • World
  • FORUM Pharmaceuticals Inc.
  • GlaxoSmithKline plc
  • Nabi Biopharmaceuticals
  • JANSSEN-CILAG OY
  • Healthcare
  • OTC
  • Smoking Cessation
  • Finland
  • Demand
  • MCNEIL DENMARK APS
  • Passport 2

IT HAS A STRONG PRESENCE IN AREAS SUCH AS NRT SMOKING CESSATION AIDS, EYE CARE AND OTHER OTC CATEGORIES.

  • OTC
  • Smoking Cessation
  • Denmark
  • Demand
  • Market Competition
  • Challenges and Opportunities Facing Nrt Smoking Cessation Aids
  • Nicorette Nrt Smoking Cessation Aids Now Available on General Sale
  • Smoking Cessation
  • Ireland
  • Demand
  • Kelkin Ltd
  • Reckitt Benckiser Group plc
  • Mar 16, 2012: Embera And Collaborators Publish Paper In Psychopharmacology Supporting EMB-001 For Smoking Cessation
  • Oct 05, 2015: Invion Successfully Completes Phase 2 Study of INV102 to Aid Smoking Cessation
  • Healthcare
  • Smoking Cessation
  • Smoking Statistics
  • United States
  • Product Initiative
  • Nov 17, 2015: Invion Phase 2 Smoking Cessation Data: Results of Ongoing Analysis
  • Mar 16, 2012: Embera And Collaborators Publish Paper In Psychopharmacology Supporting EMB-001 For Smoking Cessation
  • Pharmaceutical
  • Smoking Cessation
  • Smoking Statistics
  • United States
  • Product Initiative
  • Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) - Featured News & Press Releases
  • VARENICLINE TARTRATE - DRUG PROFILE

All patients received brief smoking-cessation counseling throughout the study.

  • Smoking Cessation
  • Europe
  • United States
  • World
  • Product Initiative
  • Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) - Product Development Milestones
  • VARENICLINE TARTRATE - DRUG PROFILE

All patients received brief smoking-cessation counseling throughout the study.

  • OTC
  • Smoking Cessation
  • Smoking Statistics
  • United States
  • Product Initiative
  • Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) - Product Development Milestones
  • VARENICLINE TARTRATE - DRUG PROFILE

All patients received brief smoking-cessation counseling throughout the study.

  • OTC
  • Smoking Cessation
  • Smoking Statistics
  • United States
  • Product Initiative

Smoking Cessation Pipeline by Stages ##.

  • OTC
  • Smoking Cessation
  • Product Initiative